Prescription at discharge of recommended treatments for secondary prevention in patients with ST-segment elevation myocardial infarction according to reperfusion strategies. Results from the IN-ACS outcome study

Acute Cardiac Care

Volumn 11, Issue 4, 2009, Pages 222-228

  Pedone, Chiara ^a   Di Pasquale, Giuseppe ^a   Greco, Cesare ^b   Gonzini, Lucio ^c   Maggioni, Aldo P ^c   Pavesi, Pier Camillo ^a   Sabini, Alessandra ^d   Boccanelli, Alessandro ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c ANMCO RESEARCH CENTER   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Myocardial infarction; Reperfusion; Secondary preventive drugs

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY PREVENTION; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; SECONDARY PREVENTION; STATISTICS, NONPARAMETRIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 72049116284     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940903215208     Document Type: Article

References (13)

1. Fox KAA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, et al. Decline rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007;297: 1892-1900
2. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/ AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction). J Am Coll Cardiol. 2008;51:210-247
3. Van de Werf F, Bax JJ, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J. 2008;29:2909-2945
4. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al; COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group). Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366: 1607-1621
5. Sabatine MS, Cannon CP, Gibson GM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189
6. Danchin N, Grenier O, Ferrières J, Cantet C, Cambou JP. Use of secondary preventive drugs in patients with acute coronay syndromes treated medically or with coronary angioplasty: results from the nationwide French Prevenir survey. Heart. 2002;88:159-162
7. Steg PG, Iung B, Feldman LJ, Cokkinos D, Deckers J, Fox KAA, et al. For the Enact Investigators. Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes. Heart. 2002;88:20-24
8. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J. 2002;23:1190-1201
9. Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, et al Canadian ACS Registries Investigators. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154:1108-1115
10. Granger CB, Steg PG, Peterson E, López-Sendón J, Van de Werf F, Kline-Rogers E, et al, GRACE Investigators. Medication performance measures and mortality following acute coronary syndromes. Am J Med. 2005;118:858-866
11. Tricoci P, Peterson ED, Roe MT. Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality improvement initiative). Am J Cardiol. 2006;98(Suppl.):30Q-5Q.
12. Di Chiara A, Fresco C, Savonitto S, Greco C, Lucci D, Gonzini L, et al on behalf of the BLITZ-2 Investigators. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J. 2006;27:393-405.
13. Heras M, Bueno H, Bardaj́ A, Fernández-Ortiz A, Mart́ H, Marrugat J, DESCARTES Investigators. Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry. Heart. 2006;92: 1571-1576